Variables | Overall Survival Median | p-Value |
---|---|---|
Age | ||
  ≤ 50 | 16.7 | 0.478 |
 >50 | 13.8 | |
Gender | ||
 Male | 12.1 | 0.120 |
 Female | 17.5 | |
Treatment | ||
 Conversion therapy | 21.1 | 0.002 |
 Palliative chemotherapy | 10.8 | |
Tumor location | ||
 Upper | 11.3 | 0.343 |
 Middle and lower | 15.7 | |
Differentiation | ||
 Poorly | 11.6 | 0.087 |
 Moderately and well | 18.1 | |
Ascites | ||
 Positive | 15.3 | 0.774 |
 Negative | 14.5 | |
Initial DSL | ||
 PCI<10 | 16.6 | 0.391 |
 PCI ≥ 10 | 13.2 | |
Second DSL | ||
 PCI<6 | 20.1 | 0.006 |
 PCI ≥ 6 | 11.3 | |
Serum CEA (ng/ml) | ||
 Normal | 15.6 | 0.373 |
 >5 | 12.0 | |
Serum CA19–9 (U/ml) | ||
 Normal | 15.9 | 0.359 |
 >39 | 12.1 | |
Serum CA125 (U/ml) | ||
 Normal | 10.4 | 0.076 |
 >35 | 17.6 |